{"anticipatedPostingDate":"2027-01","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"Cycles 1 and 3 : Day 1 predose, and Day 4 postdose; Cycles 5, 7, 12, and 24: Day 1 predose; EOT (37.11 months); and 8 weeks after the last daratumumab dose (up to 38.11 months). Each Cycle was 28 days","title":"Number of Participants With Anti-daratumumab Antibodies","type":"SECONDARY"}